DAVID WARE: Open Payments
NPI 1801852207 · EUNICE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 42 payments from 18 companies in 2025. Trend: 2023 $982 · 2024 $1,094 · 2025 $951
Food & beverage: $781Education: $170
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 3 | $146 |
| ABBVIE INC. | 5 | $105 |
| HARMONY BIOSCIENCES LLC | 2 | $92 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Lilly USA, LLC | 3 | $51 |
| Novo Nordisk Inc | 3 | $47 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $45 |
Products named: XYWAV, Auvelity, CAPLYTA, VRAYLAR, LEQVIO, MOUNJARO, LUMRYZ, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
